Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 62, Issue 3, Pages 1167-1179Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b01181
Keywords
-
Categories
Ask authors/readers for more resources
Retinoic acid receptor-related orphan receptor gamma t (ROR gamma t) agonists are expected to provide a novel class of immune-activating anticancer drugs via activation of Th17 cells and Tc17 cells. Herein, we describe a novel structure-based functionality switching approach from in house well-optimized ROR gamma t inverse agonists to potent ROR gamma t agonists. We succeeded in the identification of potent ROR gamma t agonist 5 without major chemical structure change. The biochemical response was validated by molecular dynamics simulation studies that showed a helix 12 stabilization effect of ROR gamma t agonists. These results indicate that targeting helix 12 is an attractive and novel medicinal chemistry strategy for switching existing ROR gamma t inverse agonists to agonists.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available